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Abstract 
Activated partial thromboplastin time (aPTT) is coagulation test which detect the 
disturbances of hemostasis and it is the most common test for monitoring unfractioned 
heparin therapy. In parcial tromboplastin are present activators of contact phase and 
phospholipids which can significantly affect the sensitivity of reagents to coagulation factors, 
lupus anticoagulans and heparin. 
The objective of this study was firstly to compare the sensitivity of parcial 
tromboplastins with different origins of fosfolipids and various activators to lupus 
anticoagulans, to decreased and increased levels of coagulation plasmatic factor VIII and 
sensitivity to standard heparin. Secondly, according to measured data to determine whether 
any of the selected reagents is suitable for monitoring heparin while being able to detect 
deficit of coagulation factors and presence of inhibitor. 
Determination of aPTT was performed with five different reagents which had various 
phospholipids and activators. The measurements of aPPT were performed on automatic 
analyzer BCSXP. 
From the measured data we have found that none of the tested tromboplastins had 
100% sensitivity to all referred factors. Pathromtin SL is mainly used for coagulation 
screening and monitoring heparin therapy. Pathromtin SL a APTT LS appear to be the most 
sensitive for decreasing the level of factor VIII. The best for high levels of factor VIII is 
APTT LS and for screening of Lupus anticoagulans the most sensitive are APTT SP, APTT 
LS a Pathromtin SL. 
 
